The Clinical Implications of Nocebo Effects for Biosimilar Therapy

Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?

(2019) Daniel C. Baumgart et al.   Frontiers in Pharmacology

To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars

(2018) Mourad F. Rezk et al.   ADVANCES IN THERAPY

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

(2018) Hillel P. Cohen et al.   DRUGS

The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

(2018) David Pineles et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The nocebo effect challenges the non-medical infliximab switch in practice

(2018) N. W. Boone et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

American Society of Clinical Oncology Statement: Biosimilars in Oncology

(2018) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus

(2018) Andrea W.M. Evers et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Nocebo Phenomena in Medicine

(2018) Winfried Häuser et al.   Deutsches Arzteblatt International

The nocebo effect: a clinical challenge in the era of biosimilars

(2018) Lieven Pouillon et al.   Expert Review of Clinical Immunology

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

(2018) Sizheng Zhao et al.   Current Rheumatology Reports

The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies

(2018) Johlee S. Odinet et al.   Journal of Managed Care & Specialty Pharmacy

Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect

(2018) Vincent Germain et al.   ANNALS OF THE RHEUMATIC DISEASES

Nocebos in rheumatology: emerging concepts and their implications for clinical practice

(2018) Evrydiki Kravvariti et al.   Nature Reviews Rheumatology

Placebo hypoalgesia: above and beyond expectancy and conditioning

(2018) Chika Okusogu et al.   Current Opinion in Behavioral Sciences

Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance

(2017) Marc Scherlinger et al.   JOINT BONE SPINE

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

(2017) Kristin K Jørgensen et al.   LANCET

Nocebo effects can make you feel pain

(2017) Luana Colloca   SCIENCE

Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia

(2017) A. Tinnermann et al.   SCIENCE

Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab

(2017) Lieke Tweehuysen et al.   Arthritis & Rheumatology

A systematic review of sex differences in the placebo and the nocebo effect

(2017) Sara Vambheim et al.   Journal of Pain Research

Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans

(2017) Danielle J. P. Bartels et al.   PLoS One

Policies for biosimilar uptake in Europe: An overview

(2017) Evelien Moorkens et al.   PLoS One

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

(2016) Hillel Cohen et al.   ADVANCES IN THERAPY

The changing landscape of biosimilars in rheumatology

(2016) Thomas Dörner et al.   ANNALS OF THE RHEUMATIC DISEASES

Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

(2016) Ira Jacobs et al.   BIODRUGS

A systematic review of factors that contribute to nocebo effects.

(2016) Rebecca K. Webster et al.   HEALTH PSYCHOLOGY

Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn’s and Ulcerative Colitis Associations: Table 1.

(2016) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

Biosimilars in IBD: from theory to practice

(2016) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Sources of Placebo-Induced Relief From Nausea

(2016) Veronica Frances Quinn et al.   PSYCHOSOMATIC MEDICINE

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

(2016) Ira Jacobs et al.   Patient Preference and Adherence

Changes in perception of treatment efficacy are associated to the magnitude of the nocebo effect and to personality traits

(2016) Nicole Corsi et al.   Scientific Reports

Determinants of nocebo effect during oral drug provocation tests

(2015) S. Bavbek et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

The imagined itch: brain circuitry supporting nocebo-induced itch in atopic dermatitis patients

(2015) V. Napadow et al.   ALLERGY

Patient-centred care in established rheumatoid arthritis

(2015) M.J.H. Voshaar et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data

(2015) Elena Nikiphorou et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Nocebo Effects in the Treatment of Major Depression

(2015) Seetal Dodd et al.   JOURNAL OF CLINICAL PSYCHIATRY

Placebo effects and their determinants in gastrointestinal disorders

(2015) Sigrid Elsenbruch et al.   Nature Reviews Gastroenterology & Hepatology

Placebo effect of medication cost in Parkinson disease: A randomized double-blind study

(2015) A. J. Espay et al.   NEUROLOGY

The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases

(2014) Mustafa Al Maini et al.   CLINICAL RHEUMATOLOGY

Role of explicit verbal information in conditioned analgesia

(2014) E. Carlino et al.   EUROPEAN JOURNAL OF PAIN

Tumor Necrosis Factor-Alpha Antagonists Twenty Years Later

(2014) Anthony A. Akobeng et al.   INFLAMMATORY BOWEL DISEASES

Avoiding Nocebo Effects to Optimize Treatment Outcome

(2014) Ulrike Bingel   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Role of Conditioning and Verbal Suggestion in Placebo and Nocebo Effects on Itch

(2014) Danielle J. P. Bartels et al.   PLoS One

A scoping review of scoping reviews: advancing the approach and enhancing the consistency

(2014) Mai T. Pham et al.   Research Synthesis Methods

2012 David Sun Lecture: Helping Your Patient by Helping Yourself—How to Improve the Patient–Physician Relationship by Optimizing Communication Skills

(2013) Douglas A Drossman   AMERICAN JOURNAL OF GASTROENTEROLOGY

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

(2013) Paul Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Sharing pain and relief: neural correlates of physicians during treatment of patients

(2013) K B Jensen et al.   MOLECULAR PSYCHIATRY

The nocebo effect: patient expectations and medication side effects

(2013) Kate Faasse et al.   POSTGRADUATE MEDICAL JOURNAL

To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent

(2012) Rebecca Erwin Wells et al.   AMERICAN JOURNAL OF BIOETHICS

The nocebo effect: A clinicians guide

(2012) João Data-Franco et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes

(2012) Luana Colloca et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Induction of nocebo and placebo effects on itch and pain by verbal suggestions

(2011) Antoinette I.M. van Laarhoven et al.   PAIN

The Nocebo Effect and Its Relevance for Clinical Practice

(2011) Luana Colloca et al.   PSYCHOSOMATIC MEDICINE

The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil

(2011) U. Bingel et al.   Science Translational Medicine

Doctors'non-verbal behaviour in consultations: look at the patient before you look at the computer

(2010) Jonathan Silverman et al.   BRITISH JOURNAL OF GENERAL PRACTICE

How the number of learning trials affects placebo and nocebo responses

(2010) Luana Colloca et al.   PAIN

Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer

(2009) Maxine de la Cruz et al.   CANCER

Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials

(2009) Winfried Rief et al.   DRUG SAFETY

Gender and the nocebo response following conditioning and expectancy

(2009) Sibylle Klosterhalfen et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

A systematic review of adverse events in placebo groups of anti-migraine clinical trials

(2009) Martina Amanzio et al.   PAIN

Commercial Features of Placebo and Therapeutic Efficacy

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The role of learning in nocebo and placebo effects

(2008) L. Colloca et al.   PAIN